检索

期
标题
作者
卷 95, 编号 12 (2023)
Real-world experience with netakimab in the treatment of spondyloarthritis
Meshkov A., Vorobyeva N., Ostapenko V., Pykhtina V., Ruzanova V., Perlova O., Kordyukova I., Naumov A., Khovasova N., Tkacheva O.
PDF
(Rus)
卷 94, 编号 2S (2022)
Visceral sensitivity in diagnostics and treatment of severe irritated bowel syndrome
Makarova A., Diukova G., Ruchkina I., Romashkina N., Indejkina L., Degterev D., Dbar S., Parfenov A.
PDF
(Rus)
卷 94, 编号 10 (2022)
Sub-analyses of the DAPA-CKD study: new data on the use of sodium-glucose cotransporter type 2 inhibitor in the treatment of chronic kidney disease
Shamkhalova M., Sukhareva O., Shestakova M.
PDF
(Rus)
卷 81, 编号 5 (2009)
Effects of renin-angiotensin system blockers on left ventricular hypertrophy and biochemical markers of collagen balance in patients with hypertensive hypertrophy
Ovchinnikov A., Serbul V., Ageev F., Ovchinnikov A., Serbul V., Ageev F.
卷 88, 编号 9 (2016)
Role of vascular remodeling markers in the development of osteoporosis in idiopathic pulmonary arterial hypertension
Nevzorova V., Kochetkova E., Ugay L., Maistrovskaya Y., Khludeeva E.
PDF
(Rus)
卷 82, 编号 11 (2010)
Raltegravir is the first HIV integrase inhibitor as part of antiretroviral treatment regimens
Kravchenko A., Kravchenko A.
卷 86, 编号 9 (2014)
A fixed-dose lisinopril and amlodipine combination in conjunction with rosuvastatin in patients with hypertensive disease and coronary heart disease
Galeeva Z., Galiavich A.
卷 82, 编号 2 (2010)
The parameters of collagen proteolytic and metabolic systems in chronic liver diseases of viral and toxic etiologies
Beloborodova E., Beloborodova E., Akbasheva O., Serebrov V., Chernogoryuk G., Rachkovskiy M., Purlik I., Ostanko V., Chvyrina D., Beloborodova E., Beloborodova E., Akbasheva O., Serebrov V., Chernogoryuk G., Rachkovsky M., Purlik I., Ostanko V., Chvyrina D.
卷 92, 编号 12 (2020)
Diagnosis of thrombotic thrombocytopenic purpura
Galstyan G., Klebanova E.
PDF
(Rus)
卷 85, 编号 2 (2013)
Boceprevir: New possibilities for the antiviral treatment of chronic hepatitis C
Nikitin I., Baĭkova I., Gogova L., Volynkina V., Kisliakov V.
卷 92, 编号 5 (2020)
Possibility of complex medicamental and endovascular treatment of pulmonary hypertension in Takayasu arteritis with predominant pulmonary arteries’ lesion
Маrtynuk T., Aleevskaya A., Gramovich V., Danilov N., Korobkova I., Matchin U., Solodovnikova L., Beketova T.
PDF
(Rus)
卷 84, 编号 8 (2012)
The efficiency and safety of adalimumab treatment in patients with active rheumatoid arthritis unresponsive to standard therapy: Russian national study results
Karateev D., Nasonov E., Luchikhina E., Mazurov V., Salikhov I., Shmidt E., Shostak N.
卷 81, 编号 2 (2009)
Regulators of fibrinolysis in chronic viral pathology of the liver
Yagoda A., Kopoy P., Yagoda A., Koroi P.
卷 90, 编号 9 (2018)
PCSK9 Inhibitor causes a decrease in the level of oxidatively modified low-density lipoproteins in patients with coronary artery diseases
Lankin V., Tikhaze A., Viigimaa M., Chazova I.
PDF
(Rus)
卷 84, 编号 5 (2012)
THE LEVELS OF PLASMINOGEN AND INHIBITOR OF PLASMINOGEN ACTIVATORS OF TYPE 1 IN ANTIPHOSPHOLIPID SYNDROME
Ostryakova E., Reshetnyak T., Aisina R., Mukhametova L., Gulin D., Alexandrova E., Seredavkina N., Varfolomeev S., Chernyakov A., Nikiforov Y., Nasonov E.
卷 80, 编号 6 (2008)
The role of matrix metalloproteinases in pathogenesis of renal disease
Bobkova I., Kozlovskaia L., Li O.
卷 89, 编号 12 (2017)
Effect of an angiotensin-converting-enzyme inhibitor on the plasma concentration of cytokines and vasoactive molecules in patients with coronary heart disease and hypertension
Khadartsev A., Logatkina A., Terekhov I., Bondar S., Bondar N.
卷 83, 编号 12 (2011)
Thrombin-activated inhibitor of fibrinolysis and efficacy and safety of long-term warfarin treatment in patients with venous thromboembolic complications
Vorob'eva N., Panchenko E., Dobrovol'skiy A., Titaeva E., Ermolina O., Balakhonova T., Khasanova Z., Postnov A., Kirienko A., Vorobyeva N., Panchenko E., Dobrovolsky A., Titaeva E., Ermolina O., Balakhonova T., Khasanova Z., Postnov A., Kirienko A.
卷 79, 编号 12 (2004)
Efficacy and tolerance of stepwise therapy withmovalis in rheumatic diseases
Tsvetkova E.
卷 89, 编号 8 (2017)
Chronic gastritis: Instructions for use of medications
Simanenkov V., Vyalov S.
PDF
(Rus)
卷 83, 编号 4 (2011)
Renin-angiotensin-aldosteron system: evolution of views from renin discovery to nowadays. Perspectives of therapeutic block
Shestakova M., Shestakova M.
卷 89, 编号 5 (2017)
New horizons in the use of biological agents during pregnancy in patients with rheumatic disease
Shesternya P., Petrova M., Vasilyeva A.
PDF
(Rus)
卷 83, 编号 6 (2011)
Determination of urinary markers of proteolysis/fibrinolysis and fibroangiogenesis in the kidney in hypertensive patients
Nanchikeeva M., Kozlovskaya L., Rameev V., Fomin V., Bulanov N., Nanchikeeva M., Kozlovskaya L., Rameev V., Fomin V., Bulanov N.
1 - 23 的 23 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##